RecruitingNot Applicable

European Prospective Registry on Anomalous Aortic Origin of the Coronary Arteries

Italy, Switzerland500 participantsStarted 2019-01-01

Plain-language summary

Anomalous aortic origin of a coronary artery (AAOCA) is a group of rare congenital heart defects with various clinical presentations. The lifetime-risk of an individual living with AAOCA is unknown, and data from multicentre registries are urgently needed to adapt current recommendations and guide optimal patient management. The European Registry for AAOCA (EURO-AAOCA) aims to assess differences with regard to AAOCA management between centres.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients with a diagnosis of AAOCA (either referred to surgery or to medical follow-up ) Exclusion Criteria: * isolated high-coronary take-off (≥ 5mm above sino-tubular junction), anomalous origin of a circumflex from the right coronary artery, anomalous course with a normal origin, and association to major congenital heart disease (i.e. Tetralogy of Fallot, transposition of the great arteries, anomalous origin of a coronary from the pulmonary artery).

What they're measuring

Incidence of Symptoms at diagnosis and after surgery

Timeframe: 5 years

Incidence of postoperative adverse events

Timeframe: 5 years

Incidence of adverse events at follow up

Timeframe: 5 years

Trial details

NCT IDNCT06089902

SponsorUniversity of Padova

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-01-01

Contact for this trial

Massimo Padalino, MD PhD

00393408922564 massimo.padalino@unipd.it

View on ClinicalTrials.gov More Congenital Heart Disease trials